4//SEC Filing
GLOBAL MED TECHNOLOGIES INC 4
Accession 0001209191-10-019718
CIK 0001009463operating
Filed
Mar 31, 8:00 PM ET
Accepted
Apr 1, 2:49 PM ET
Size
17.3 KB
Accession
0001209191-10-019718
Insider Transaction Report
Form 4
HAEMONETICS CORP
10% Owner
Transactions
- Other
Common Stock
2010-03-25$1.22/sh+103,700$126,514→ 31,532,430 total(indirect: See Footnote) - Other
Common Stock
2010-03-29$1.22/sh+1,590,800$1,940,776→ 33,950,533 total(indirect: See Footnote) - Other
Common Stock
2010-03-26$1.22/sh+827,303$1,009,310→ 32,359,733 total(indirect: See Footnote) - Other
Common Stock
2010-03-31$1.22/sh+406,519$495,953→ 34,398,052 total(indirect: See Footnote) - Other
Common Stock
2010-04-01$1.22/sh+1,036,776$1,264,867→ 35,434,828 total(indirect: See Footnote) - Other
Common Stock
2010-03-30$1.22/sh+41,000$50,020→ 33,991,533 total(indirect: See Footnote)
Atlas Acquisition Corp.
10% Owner
Transactions
- Other
Common Stock
2010-03-26$1.22/sh+827,303$1,009,310→ 32,359,733 total(indirect: See Footnote) - Other
Common Stock
2010-03-29$1.22/sh+1,590,800$1,940,776→ 33,950,533 total(indirect: See Footnote) - Other
Common Stock
2010-03-30$1.22/sh+41,000$50,020→ 33,991,533 total(indirect: See Footnote) - Other
Common Stock
2010-03-25$1.22/sh+103,700$126,514→ 31,532,430 total(indirect: See Footnote) - Other
Common Stock
2010-03-31$1.22/sh+406,519$495,953→ 34,398,052 total(indirect: See Footnote) - Other
Common Stock
2010-04-01$1.22/sh+1,036,776$1,264,867→ 35,434,828 total(indirect: See Footnote)
Footnotes (5)
- [F1]In accordance with the Agreement and Plan of Merger (the "Merger Agreement"), dated as of January 31, 2010, by and among Haemonetics Corporation, a Massachusetts corporation ("Haemonetics"), Atlas Acquisition Corp., a Colorado corporation and a direct wholly-owned subsidiary of Haemonetics, and Global Med Technologies, Inc., a Colorado corporation ("Global Med"), Atlas Acquisition Corp. commenced a cash tender offer (the "Offer") to purchase all outstanding shares of Global Med Common Stock, $0.01 par value per share (the "Common Shares"), and Series A Convertible Preferred Stock, $0.01 par value per share ("Preferred Shares"), subject to the terms and conditions set forth in the Offer to Purchase, dated February 19, 2010, as amended (the "Offer to Purchase"), included as an exhibit to the Tender Offer Statement on Schedule TO filed by Haemonetics and Atlas Acquisition Corp. with the Securities and Exchange Commission on February 19, 2010.
- [F2]The reported Common Shares were purchased during the subsequent offering period contemplated by the Merger Agreement and the Offer to Purchase.
- [F3]Excludes 5,500,000 Common Shares issuable upon conversion of 3,960 Preferred Shares of the Issuer, which Preferred Shares are subject to "blocker" provisions prohibiting the holder from converting the Preferred Shares to the extent that such conversion would result in the holder becoming the beneficial owner of more than 9.99% of the outstanding Common Shares.
- [F4]The reported securities are owned indirectly by Haemonetics and directly by Atlas Acquisition Corp.
- [F5]The reported Common Shares were purchased upon exercise of the "top-up option" contemplated by the Merger Agreement and the Offer to Purchase.
Documents
Issuer
GLOBAL MED TECHNOLOGIES INC
CIK 0001009463
Entity typeoperating
IncorporatedCO
Related Parties
1- filerCIK 0001009463
Filing Metadata
- Form type
- 4
- Filed
- Mar 31, 8:00 PM ET
- Accepted
- Apr 1, 2:49 PM ET
- Size
- 17.3 KB